✦ LIBER ✦

PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma

✍ Scribed by Kan, H.C.; Pwu, R.F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS

✍ H. Arreola-Ornelas; A. Rosado-Buzzo; M. Garcia-Mollinedo; L. Camacho; J.F. Mould 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF TEM

✍ NM Silverio; S Yang; E Alemao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PCN39 COST-EFFECTIVENESS AND BUDGET IMPA

✍ V Bonthapally; S Ghosh; H Rappaport 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN70 COST EFFECTIVENESS ANALYSIS OF SUN

✍ E Remák; H Vioix; R Sandin; U Harmenberg; A Ullén; P Sandström 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN62 Cost-Effectiveness Analysis of Fir

✍ Nuñez, S.M.; Godoy, J.I.; Cardona, A.F.; Otero, J.M.; Lujan, M.; Lopera, D.; Car 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN56 COST OF RENAL CELL CARCINOMA TREAT

✍ T Purmonen; R Vuorinen; V Kataja; S Pyrhönen; P Kellokumpu-Lehtinen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB